DLHC - DLH Holdings Forward P/S Multiple

Public company logo of dlhcorp.com (DLHC)

A steady inflow of funds from the public sector eliminates capital deficits, supporting the future P/S multiple valuation, where the current figure stands at 0.20. DLH Holdings Corp. (DLHC) bases its financial stability on long-term agreements with the Department of Veterans Affairs. Operational flexibility is ensured by leveraging external IT partners and staffing resources to implement large-scale defense programs within the healthcare sector.

DLH Corp - DLHC Market Cap to Expected Sales Ratio (period 07/04/2022 - 11/16/2026)

Analytical breakdowns and data insights for company DLH Corp (DLHC)

- market price and analyst price targets:
Comprehensive company analysis:DLH Holdings (DLHC)
Product sample of DLH Holdings

The forward P/S reflects the market value of DLH Holdings Corp. (DLHC) relative to projected sales volume, allowing for an assessment of the premium investors are willing to pay per unit of expected revenue. The growth in the forward price-to-sales ratio confirms market confidence in the scaling of IT contracts with the US public sector for veterans' health monitoring and data protection, separating fundamental optimism from short-term price fluctuations.

Key competitors

Price-to-Projected Revenue Ratio Veeva Corp VEEV|Price to Expected Revenue Ratio DOCS (Doximity, Inc.)|HQY: Forward Price-to-Revenue Multiple|Forward Price to Sales WAY (waystar.com)|CorVel Corp. (CRVL) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Privia Health (PRVA)|Price-to-Projected Revenue Ratio Huron Corp|Market Cap to Projected Revenue CERT (Certara Corp)|Price-to-Projected Revenue Ratio Omnicell (OMCL)|GoodRx Holdings, Inc. - Market Cap to Projected Revenue|Schrödinger - Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio Phreesia Inc (PHR)|OMDA: Forward Price-to-Revenue Multiple|Forward Price to Sales EVH (Evolent Health, Inc.)|HSTM: Forward P/S Multiple|DH: Price to Expected Revenue Ratio|CCSI (Consensus) - Forward P/S Multiple|Price-to-Projected Revenue Ratio AGL|Forward P/S Multiple ABSI|Market Cap to Expected Sales Ratio So-Young Corp|Price-to-Projected Revenue Ratio National Research NRC|SPOK - Forward Price-to-Revenue Multiple|optimizerx.com - Forward P/S Multiple|Projected Price to Revenue TruBridge (TBRG)|SLP: Forward P/S Multiple|SOPH - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple HCAT|CCLD (CareCloud) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio researchsolutions.com (RSSS)|OneMedNet Corp - Market Cap to Projected Revenue|Forward P/S Multiple SCNX (Scienture Corp)|Price to Expected Revenue Ratio HCTI (Healthcare Triangle Corp)|iSpecimen Corp - Forward P/S Multiple|Forward Price to Sales BFRG (bullfrogai.com)|WORX: Forward P/S Multiple|Forward Price-to-Revenue Multiple MSP Recovery|Price-to-Projected Revenue Ratio icoreconnect.com|MEDS: Forward Price to Sales|Price-to-Projected Revenue Ratio Orgenesis Inc. (ORGS)|Market Cap to Expected Sales Ratio R1 RCM, Inc.|Forward P/S Multiple SHCR (sharecare.com)|Market Cap to Expected Sales Ratio Streamline Health Solutions, Inc. (STRM)|SYRA - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio Apollo Medical Holdings Inc. AMEH|Model N (MODN) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue NXGN